Meet all our speakers

Saif Abed

Founding Partner, AbedGraham, Cyber Security Expert

European Commission and WHO

Robert Abbott

Vice President, Chief Legal Counsel EMEA

Stryker

Hani Abouhalka

Company Group Chairman - Medical Devices EMEA

Johnson & Johnson

Marcello Agosti

Global Business Development Officer

Takeda

Renée Aguiar-Lucander

CEO

Calliditas

Shafi Ahmed

CMO

Medical Realities

Ingrid Akay

Managing Partner

Hadean Ventures

Maarten Akkerman

VP Medical Affairs & Value-Based Healthcare EMEA

Medtronic

Sascha Alilovic

Partner

SHS Capital

Mark Altmeyer

CEO

Arvelle Therapeutics

Michael Altorfer

CEO

SwissBiotech

Derk Arts

CEO

Castor

Steve Atkinson

CEO

Atlantic Healthcare

Frances Ayalasomayajula

Head of Population Health

HP

Caroline Barelle

CEO

Elasmogen

Assaf Barnea

CEO

Sanara Ventures

Pierre Belichard

CEO

Enterome Bioscience

Gregory Benning

MD & Group Head M&A

Back Bay Life Science Advisors

Xavier Bertrand

Vice President Healthcare Services and Alliances EMEA

Boston Scientific

Alessio Beverina

Managing Partner

Panakes Partners

Maina Bhaman

Partner

Sofinnova

Peter Bisgaard

Managing Director

Nan Fung Life Sciences

Jeanne Bolger

Vice President, Venture Investments

Johnson & Johnson Innovation

Elena Bonfiglioli

MD Health Industry EMEA

Microsoft

Eduardo Bravo

CEO

Nordic Nanovector

Søren Bregenholt

CEO

Macrophage

Paul Brown

Chief Financial Officer

North West London CCGs, NHS England

Seamus Browne

Head of Industry Partnerships

Royal College of Surgeons

Roel Bulthuis

Managing Director

Inkef Capital

Sergio Capancioni

Director Search & Evaluation Western Europe

AbbVie

Lifei Cheng

Founder & CEO

MedTecx

Katherine Cohen

Venture Partner

Panacea Ventures

Stuart Collinson

CEO

Oxstem

Edward Cox

CEO

Dthera Sciences

Adelaide Cracco

Head of Life Sciences

European Investment Fund

Laia Crespo

Head of Europe

Sanofi Ventures

Ian Crosbie

CEO

Sequana Medical AG

Jane Dancer

CBO

F-Star

Nissim Darvish

Senior Managing Director

OrbiMed

John Dawson

CEO

Oxford BioMedica

Susana de Azevedo Wäsch

VP Quality Management & Regulatory Affairs

Ypsomed AG

Don deBethizy

Chair of Board

Saniona AB

Fiona de Hemptinne

Venture Partner

UCB Ventures

Rudy Dekeyser

Managing Partner

LSP Health Economics Fund

Richard di Benedetto

President

Aetna International

Luc Dochez

Managing Director

PrimixBioVentures

Joe Dupere

CEO

Rexgenero

Johnston Erwin

VP Corporate Business Development

Eli Lilly

Kristien Esser

CEO

Guided Solutions

Sarah Fisher

Senior Director, Global Markets, External Innovation

Johnson & Johnson

Mathias Flume

Head of Department

KVWL

Miriam Frieden

VP Search & Evaluation

Novo Nordisk

Martin Frost

CEO

CMR Surgical

Caroline Gaynor

Vice President

Lightstone Ventures

Manuela Gazzard

Group Executive Director, Regulatory Services Healthcare

BSI Group

David Germonpré

Investment Partner

MTIP

Jonathan Gertler

Managing Partner & CEO

Back Bay Life Science Advisors

Hakan Goker

Senior Investment Director

M Ventures

Jonathan Goldstein

Partner

Boston Scientific

Mathias Goyen

CMO Europe

GE Healthcare

Theo Harold

CEO

Crescendo Biologics

Ori Hadomi

CEO

Mazor Robotics

Mattias Haeggblom

Portfolio Manager

Swedbank Robur

Deborah Harland

Partner

SR One

Zishan Haroon

Chairman & General Partner

Julz Co LLC

Mark-Jan Harte

Co-Founder & CEO

Aidence

Olav Hellebo

CEO

ReNeuron Group

Jens Hennecke

CBO

Sotio AS

David Horn Solomon

CEO

Silence Therapeutics

Leon Hooftman

CMO

ISA Pharmaceuticals

Alice Hu Wagner

Managing Director

British Business Bank

Thomas Hummel

Head of Innovation & Strategy

Siemens Healthineers

Sofia Ioannidou

Partner

Andera Partners

Annalisa Jenkins

Chair to European biotechs

Arnd Kaltofen

General Partner

VI Partners

Edward Kliphuis

Investment Director

M Ventures

Adam Kostyal

SVP

Nasdaq

Charity Kufaas

VP BD

Medtronic

Phil L’Hullier

Head of BD, Europe, European Innovation Hub

MSD

Jacques Lafon

President Medical Segment, EMEA

Cardinal Health

Werner Lanthaler

CEO

Evotec

Kevin Lee

CEO

Bicycle Therapeutics

Søren Lemonius

Managing General Partner

Sunstone Life Science Ventures

Leon Lerman

CEO & Co-Founder

Cynerio

Karen Liu

Partner

3E BioVentures

Thomas Lönngren

Former Head of EMA & Advisor

NDA

Philippe Lopes-Fernandes

SVP, Global Head of BD & Alliance Management

Merck KGaA

Tim Luker

Senior Director External Innovation

Eli Lilly

Frank Maddux

Global CMO

Fresenius Medical Care

Dave Madge

VP of the Research Service Division

WuXi AppTec

Ivana Magovčević-Liebisch

CBO

Ipsen

Anoop Maini

CEO

Excite Ventures

Sean Marett

CBO, CCO

BioNTech AG

Giovanni Mariggi

Partner

Medicxi

Craig Marshall

CEO

OrganOx

Ben Maruthappu

CEO

Cera

Giuseppe Mazza

CEO

Engitix

John E Milad

CEO

Quanta Dialysis

Edwin Moses

former CEO Ablynx and Chairman to European biotechs

Bibhash Mukhopadhyay

Principal

New Enterprise Associates

Sumit Nagpal

Founder & CEO

CareFully

Jordi Naval

CEO

Biocat

Jack Nielsen

MD

Vivo Capital

Mark O'Herlihy

MD EMEA

IBM Watson Health

Geraldine O’Keeffe

Partner Public Equities

LSP

Daniel O’Mahony

Partner

Seroba Life Sciences

Francis Pang

VP Global Market Access

Orchard Therapeutics

Anthony Pagano

SVP Finance & Corporate Development

Genmab

Martin Pfister

Senior Investment Manager

High-Tech Gründerfonds

Laura Piccinini

Global Head of Commercial Operations

Envista Holdings Corporation

Catherine Pickering

CEO

iOnctura

James Pink

Executive Vice President - Consulting

NSF Health Sciences

John Power

CEO

Aerogen

Ena Prosser

Partner

FH Partners

Vivek Ramaswamy

CEO

Roivant Sciences

Mike Romanos

CEO

Microbiotica

Kieran Rooney

VP Strategic Alliances and Licensing

Amryt Pharma

Bernard Ross

CEO & Founder

First Kind Medical

Thibaut Roulon

Investment Director - Life Sciences

Bpifrance

Christoph Ruedig

Partner

Albion Capital

Mirko Scherer

CEO

CoFeS China Ltd

Eliane Schutte

CEO

Xeltis

Denise Scots-Knight

CEO

Mereo Biopharma

Sara Secall

Investment Director & Partner

Inveready Asset Management

Graziano Seghezzi

Managing Partner

Sofinnova Partners

Sarah Shackleton

Partner, Marketing & Talent

Abingworth

Nigel Sheail

Global Head of M&A and BD&L

Novartis

Kyparissia Sirinakis

Managing Partner

Epidarex

Ulrica Slåne Bjerke

CIO

Arctic Aurora LifeScience

Yochi Slonim

Co-Founder & CEO

Anima Biotech Inc

Sander Slootweg

Managing Partner

Forbion

Patrik Sobocki

Investor

Industrifonden

Jens Stegemann

Former CEO

Breath Therapeutics

Carl Sterritt

CEO

Shield Therapeutics

Rainer Strohmenger

Managing Partner

Wellington Partners

Steve Swinson

Chair, Comphya and Tibbyah Holdings, Former Chair

Acteon, Vexim, Bone Therapeutics

Chas Taylor

CEO & Executive Director

Veryan Medical

Rafaèle Tordjman

Founder & CEO

Jeito

Luella Trickett

Director Value and Access

Association of British HealthTech Industries

David Tuch

CEO

Lightpoint Medical

Peter Ullrich

CEO

Titan Spine

Todd Usen

CEO

Activ Surgical

Onno Van de Stolpe

CEO

Galapagos

Erik van den Berg

CEO

AM-Pharma

Vanessa Vankerckhoven

CEO & Co-Founder

Novosanis NV

Montserrat Vendrell

General Partner

Alta Life Sciences

Cedric Ververken

CEO

Confo Therapeutics

Guillaume Vignon

SVP Business Development

BeiGene

Eline Vrijland-Van Beest

Partner

Blue Sparrows MedTech Fund

Jason Ward

Group Director

AstraZeneca

Ian Wilson

CEO

ImaginAb

Rupert Winckler

Head of EMEA Business Development

Olympus

Marietta Wu

Managing Director

Quan Capital

Andreas Wuepper

Partner

Fresenius Medical Care

Donald Xu

Managing Partner

Lynx Financial

Frank Yu

CEO

Ally Bridge Group

Dan Zhang

Executive Chairman

Fountain Medical Development

Constantinos Ziogas

Head of SME Office

European Medicines Agency

Lars van der Veen

COO

iOnctura